Related Experiment Video
Updated: Jun 19, 2026

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
The Empirical Bayes Variational Autoencoder-A Neural ODE Approach for Population Modeling in Pharmacology
Marcus Baaz1, Anders Sjöberg1,2, Mats Jirstrand1,2
1Fraunhofer-Chalmers Centre, Gothenburg, Sweden.
Abstract:
Variational autoencoders (VAEs) combined with neural ordinary differential equations provide a flexible framework for exploring neural latent-variable models in population pharmacokinetics. In this work, we investigate an empirical Bayes VAE formulation that integrates encoder-decoder architectures with covariate-dependent population priors, enabling correlated latent representations and probabilistic inference. We evaluate the proposed framework using controlled simulation studies and a small clinical benchmark dataset. The simulation experiments assess the ability to recover known population structures and covariate effects, while the clinical study evaluates subject-specific prediction and model diagnostics. In simulation studies with correlated individual parameters, the empirical Bayes VAE consistently captured population-level variability, whereas a fixed-prior VAE baseline exhibited systematic biases. In our experiments, extrapolation beyond the training dosing schedules showed more stable predictive behavior when using the proposed input-response normalization, relative to models trained without normalization, within a limited range. Diagnostic analyses indicated clear relationships between inferred latent variables and true parameters, and estimated observation noise was consistent with simulated values. In the clinical case study, cross-validation experiments suggested predictive performance comparable to previously reported neural ODE-based approaches. Overall, the results illustrate the feasibility of combining empirical Bayes inference with neural ODE-based decoders for population modeling. The proposed framework should be viewed as a methodological proof-of-concept, highlighting both the potential and the current limitations of variational neural approaches in pharmacometric applications.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis of Population Pharmacokinetic Data
Model Approaches for Pharmacokinetic Data: Physiological Models
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Pharmacodynamic Models: Overview
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
